Phosphorus-31 MR Spectroscopy in Pediatric Liver Transplant Recipients: A Noninvasive Assessment of Graft Status with Correlation with Liver Function Tests and Liver Biopsy
Winnie C. W. Chu1,
Wynnie W. M. Lam1,
Kim-hung Lee2,
David K. W. Yeung3,
Jennifer Sihoe2 and
Chung-kwong Yeung2
1 Department of Diagnostic Radiology and Organ Imaging, Faculty of Medicine, The
Chinese University of Hong Kong, Prince of Wales Hospital, Ngan Shing St.,
Shatin, Hong Kong SAR, China.
2 Department of Surgery, The Chinese University of Hong Kong, Prince of Wales
Hospital, Shatin, Hong Kong SAR, China.
3 Department of Clinical Oncology, Medical Physics Division, The Chinese
University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong SAR,
China.

View larger version (94K):
[in a new window]
|
Fig. 1. Axial T2-weighted fat-saturation MR image (TR/TE, 1,800/80)
of 11-year-old girl with left lobe transplant shows location of volume of
interest (white box) selected for phosphorus-31 MR spectroscopy
placed in central region of graft liver.
|
|

View larger version (25K):
[in a new window]
|
Fig. 2. In vivo hepatic phosphorus-31 MR spectra of healthy
7-year-old girl as control subject (spectrum A), 8-year-old girl with good
graft function after liver transplantation (spectrum B), and 11-year-old girl
with chronic hepatitis after liver transplantation (spectrum C). Spectra A and
B show similar spectral profile, but there is marked elevation in
phosphomonoester (PME) resonance (arrow) in spectrum C. Pi =
inorganic phosphate, PDE = phosphodiester, PCr = phosphocreatine, NTP =
nucleotide triphosphate.
|
|

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
Copyright © 2005 by the American Roentgen Ray Society.